Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

1.35
Delayed Data
As of 3:47pm ET
 -0.03 / -2.17%
Today’s Change
1.00
Today|||52-Week Range
4.04
-9.40%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +270.37% increase from the last price of 1.35.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since February, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
--
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 57.11%
 
 
 
 
 
 
Growthannually -9.32%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.